Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Introduction to Hemostasis01:05

Introduction to Hemostasis

14.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.2K
Coagulation01:09

Coagulation

8.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.9K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A portable, ultra-low cost, open-source, pedal-controlled microinjector for laboratory use.

PloS one·2026
Same author

TIE2 links MEKK3-KLF2/4 and PI3K signaling in cerebral cavernous malformation.

The Journal of experimental medicine·2026
Same author

Dll4 assembles the umbilical cord and placental vasculature.

JCI insight·2026
Same author

Artery formation in the intestinal wall and mesentery by intestine-derived Esm1+ endothelial cells.

Nature communications·2025
Same author

Hemodynamic forces prevent myxomatous valve disease in mice through KLF2/4 signaling.

The Journal of clinical investigation·2025
Same author

Lineage tracing studies suggest that the placenta is not a de novo source of hematopoietic stem cells.

PLoS biology·2025

Related Experiment Video

Updated: May 5, 2026

Cecal Ligation Puncture Procedure
11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

55.2K

Counteracting clotting in sepsis.

Mark L Kahn1

  • 1University of Pennsylvania, 925 BRB II/III, 421 Curie Boulevard, Philadelphia, Pennsylvania 19104, USA. markkahn@med.upenn.edu

Nature Medicine
|September 9, 2008
PubMed
Summary

Researchers explore immune thrombocytopenic purpura, a bleeding disorder, and coagulation syndromes in severe sepsis. Clinical findings offer insights into mechanisms and potential new therapies for these complex conditions.

Area of Science:

  • Hematology
  • Immunology
  • Critical Care Medicine

Background:

  • Bleeding and coagulation are complex physiological processes.
  • Immune thrombocytopenic purpura (ITP) is a common bleeding disorder with unclear mechanisms.
  • Coagulation syndromes in severe sepsis pose significant therapeutic challenges.

Purpose of the Study:

  • To elucidate the mechanistic basis of immune thrombocytopenic purpura.
  • To review research studies for improved therapies in sepsis-induced coagulation disorders.

Main Methods:

  • Examination of clinical findings related to ITP.
  • Analysis of two research studies on sepsis and coagulation.

Main Results:

  • Clinical data suggests a mechanistic understanding of ITP.

More Related Videos

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

19.3K
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.7K

Related Experiment Videos

Last Updated: May 5, 2026

Cecal Ligation Puncture Procedure
11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

55.2K
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

19.3K
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.7K
  • Identified potential therapeutic avenues for sepsis-related coagulation issues.

    • Conclusions:

    • Advances in understanding ITP are emerging from clinical observations.
    • New therapeutic strategies for sepsis-associated coagulopathy may be developed.